-
Below is contextual information regarding the design of proposed studies to support marketing approval of Over-the-Counter (OTC) home-use HIV test kits which includes an historical overview of rapid HIV test kit approval in the United States, and key issues for consideration by the FDA Blood Products Advisory Committee.
-
A new study has found a rising HIV prevalence rate in the border town of Tijuana, Mexico, and researchers say this could be the start of a disturbing trend.
-
One in six global AIDS deaths and one in seven new HIV infections worldwide are among children under age 15, Also, an estimated 15 million children are orphans because of AIDS, and in sub-Saharan Africa, this number is expected to rise to 18 million orphans by 2010.
-
Collaborators from the Armed Forces Research Institute for Medical Sciences (AFRIMS) and the Kwai River Christian Hospital assessed the causes of febrile illness in the adult population in Sangkhlaburi, Thailand, near the border with Myanmar.
-
Treatment of Benign Prostatic Hyperplasia; Treatment of Osteoarthritis of the Knee; Refractory Asthma and TNFConnection?; FDA Actions
-
-
Potential new uses of rifaximin are examined in a recent CID article by Adachi and DuPont. Rifaximin, a semisynthetic derivative of rifamycin, received FDA approval in May of 2004, for the treatment of travelers diarrhea in patients 12 years of age and older caused by non-invasive strains of E. coli.
-
In June 1998, there were numerous reports of diarrheal illness in multiple attendees of events catered by a delicatessen in Chicago, Illinois.
-
Exposure of healthcare personnel to either blood or the bloody secretions of an HIV-seropositive person has only occasionally resulted in HIV infection.
-
Fungal infections are becoming more prevalent, as Candida spp. represent the fourth most common organism recovered from blood of hospitalized patients in the United States.
